Open Access

ARTICLE

Overexpression of SASH1 Inhibits TGF-β1-Induced EMT in Gastric Cancer Cells

by

* Department of Gastroenterology, Shaanxi Provincial People’s Hospital, the Third Affiliated Hospital, College of Medicine, Xi’an Jiaotong University, Xi’an, China
† Department of Dermatology, Xijing Hospital, the Fourth Military Medical University, Xi’an, China
‡ Department of Gastroenterology, the Second Affiliated Hospital, College of Medicine, Xi’an Jiaotong University, Xi’an, China

Oncology Research 2016, 24(1), 17-23. https://doi.org/10.3727/096504016X14570992647203

Abstract

The epithelial–mesenchymal transition (EMT) is considered to be one of the critical steps in gastric cancer cell invasion and metastasis. SAM- and SH3-domain containing 1 (SASH1), a member of the SLY family of signal adapter proteins, is a candidate for tumor suppression in several cancers. However, the biological role of SASH1 in gastric cancer remains largely unknown. Therefore, the purpose of this study was to investigate the impact of SASH1 on the biological behavior of gastric cancer cells treated with transforming growth factor (TGF)-β1. In the current study, we provide evidence that SASH1 was lowly expressed in human gastric cancer cells, and TGF-β1 also inhibited the expression of SASH1 in TSGH cells. We found that SASH1 inhibited TGF-β1-mediated EMT in TSGH cells, as well as cell migration and invasion. Furthermore, SASH1 obviously inhibited the phosphorylation of PI3K and Akt in TGF-β1-stimulated TSGH cells. In summary, our study is the first to show that overexpression of SASH1 inhibits TGF-β1-induced EMT in gastric cancer cells through the PI3K/Akt signaling pathway. These results suggest that SASH1 may be a potential therapeutic target for the treatment of gastric cancer.

---

Keywords

---